Follow-up study of cardiac 123I-MIBG scintigraphy in idiopathic REM sleep behavior disorder |
| |
Authors: | Miyamoto T Miyamoto M Iwanami M Hirata K |
| |
Affiliation: | Department of Neurology, Center of Sleep Medicine, Dokkyo Medical University School of Medicine, Tochigi, Japan. sandra.olsson@neuro.gu.se |
| |
Abstract: | Background: Cardiac 123I‐metaiodobenzylguanidine (123I‐MIBG) uptake in patients with idiopathic rapid eye movement (REM) sleep behavior disorder (iRBD) is markedly reduced, as in Parkinson’s disease (PD). Methods: We performed 123I‐MIBG scintigrams on patients with iRBD and PD. After the initial 123I‐MIBG scintigram, we retested subjects after a mean of 2.8 years. Results: The delayed heart‐to‐mediastinum (H/M) ratio of cardiac 123I‐MIBG uptake was not significantly reduced between the first and second study in either group (P = 0.050, P = 0.091, respectively) . Follow‐up imaging revealed a mean decline of 4.21 ± 9.06% or 6.40 ± 19.02% in the delayed H/M ratio in those with iRBD or PD, respectively. Conclusions: The 123I‐MIBG uptake findings might indicate progression early in the course of iRBD or PD, but the progression is heterogeneous and independent of development of motor symptoms. |
| |
Keywords: | 123I‐MIBG Lewy body diseases Parkinson’s disease REM sleep behavior disorder |
本文献已被 PubMed 等数据库收录! |
|